Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
Background: The ability of anti-Müllerian hormone (AMH) to predict ovarian response has been studied extensively in gonadotropin-releasing hormone agonist and antagonist treatments, but no information is available regarding its value in progestin-primed ovarian stimulation (PPOS) protocol.Methods: T...
Main Authors: | Jialyu Huang, Jiaying Lin, Hongyuan Gao, Yun Wang, Xiuxian Zhu, Xuefeng Lu, Bian Wang, Xinyan Fan, Renfei Cai, Yanping Kuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00325/full |
Similar Items
-
Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
by: Hongjuan Ye, et al.
Published: (2018-05-01) -
Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
by: Junwei Zhang, et al.
Published: (2021-09-01) -
Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study
by: Huang J, et al.
Published: (2019-07-01) -
Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials
by: Shaogen Guan, et al.
Published: (2021-08-01) -
Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study
by: Qian Peng, et al.
Published: (2019-11-01)